Latest News and Press Releases
Want to stay updated on the latest news?
-
Kiadis Pharma kondigt goedkeuring van Amerikaanse FDA aan voor start van NK-REALM Fase 2-klinische studie voor met PM21 geproduceerde natural killer...
-
Kiadis Pharma announces U.S. FDA approval to start NK-REALM Phase 2 clinical trial for natural killer (NK) cell therapy produced with PM21 FDA approval of Investigational New Drug (IND) application...
-
THIS PRESS RELEASE AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR PUBLIC RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED...
-
...
-
THIS PRESS RELEASE AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR PUBLIC RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED...
-
Kiadis Pharma kondigt twee abstracts aan die zijn geaccepteerd als posterpresentaties op de ASGCT 2020 Virtuele Jaarvergadering Amsterdam, Nederland, 29 april 2020 - Kiadis Pharma N.V. ("Kiadis...
-
Kiadis Pharma announces two abstracts accepted for poster presentations at the ASGCT 2020 Virtual Annual Meeting Amsterdam, The Netherlands, April 29, 2020 – Kiadis Pharma N.V. (“Kiadis Pharma” or...
-
Kiadis Pharma maakt donderdag 30 april 2020 de jaarcijfers bekend over het jaar eindigend op 31 december 2019 Amsterdam, 28 april 2020 – Kiadis Pharma...
-
Kiadis Pharma to announce annual results for the year ended December 31, 2019 on Thursday April 30, 2020 Amsterdam, The Netherlands, April 28, 2020 –...
-
THIS PRESS RELEASE AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR PUBLIC RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED...